Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Coronary heart disease. It doesn’t care if you’re Canadian, American or living in India, Kenya or Spain. Political boundaries mean nothing to a condition that kills an estimated 3.8 million men and 3.4 million women globally each year.
So why shouldn’t cardiac clinical trials and research also break geographic barriers?
That’s part of the thinking behind the Peter Munk Centre of Excellence in Multinational Clinical Trials, launched in 2011 and one of seven Centres of Excellence established by the Peter Munk Cardiac Centre (PMCC) to transform the way patients with cardiovascular disease are treated around the world.
“We bring innovation and what we call the ‘one-stop shop,’” says Dr. Michael Farkouh, the PMCC Chair in Multinational Clinical Trials, who came back to Canada in 2010 after working in the United States for 20 years, including 10 years directing the Mount Sinai Cardiovascular Clinical Trials Unit in New York City.
“When we develop new drugs and new devices, we have the ability that most centres in the world do not have to go from the early concept in innovation all the way to the large clinical trial,” he says.
That’s partly due to Dr. Farkouh’s own experience running large multinational trials. While phase one and phase two trials typically involve smaller numbers of people chosen with very specific medical parameters in mind, multinational trials examine outcomes in thousands or even hundreds of thousands of people worldwide.
The third annual Peter Munk Cardiac Centre (PMCC) magazine published by
The Globe and Mail focuses on why Canada's premier cardiac centre is known for being “the heartbeat of innovation.” The magazine explores the PMCC model that supports the creation, development and evolution of innovative ideas into action – making “today's idea, tomorrow's practice.” It also examines the impact that a culture of innovation has on the way cardiovascular care is delivered now and into the future.